https://www.marketscreener.com/quote/stock/MAGENTA-THERAPEUTICS-44315921/news/Magenta-Therapeutics-Announces-First-Subjects-Dosed-in-Phase-1-Clinical-Trial-of-MGTA-145-a-First-28470954/?utm_source=telegram&utm_medium=social&utm_campaign=share